Results 51 to 60 of about 2,131 (192)

Acute glomerulonephritis associated with complicated eczema herpeticum

open access: yesPediatria i Medycyna Rodzinna, 2019
Primary acute glomerulonephritis is a disease of the glomeruli with a sudden onset. It is caused by the presence of immune complexes following group A beta-haemolytic streptococcus infection. This is usually due to a streptococcus infection of the throat
Marta Fiedorowicz-Kaźmierczak   +3 more
doaj   +1 more source

An Update on Airborne Contact Dermatitis: 2001-2006 [PDF]

open access: yes, 2007
Reports on airborne dermatoses are mainly published in the context of occupational settings. Hence, in recent years, dermatologists and also occupational physicians have become increasingly aware of the airborne source of contact dermatitis, resulting ...
Goossens, A, Santos, R
core   +1 more source

Baricitinib for atopic dermatitis patients who responded inadequately to dupilumab treatment:First daily practice results [PDF]

open access: yes, 2022
Background: Baricitinib is the first JAK inhibitor registered for the treatment of moderate-to-severe atopic dermatitis (AD). Efficacy and safety were shown in clinical trials, but daily practice data is sparse.
de Wijs, Linde   +4 more
core   +4 more sources

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants [PDF]

open access: yes, 2015
Atopic dermatitis (AD) is a distressing dermatological disease, which is highly prevalent during infancy, can persist into later life and requires long-term management with anti-inflammatory compounds.
Boguniewicz, Mark   +25 more
core   +6 more sources

Miscellanea. Folyóirat-referátumok. Könyvismertetés [PDF]

open access: yes, 2016
Addiktológia. Új HIV-esetek Magyarországon az injekciós droghasználók körében: Téves riasztás vagy korai figyelmeztetés? (New cases of HIV among people who inject drugs in Hungary: False alarm or early warning?) Rácz, J., Gyarmathy, V. A.,
Apor, Péter   +5 more
core   +1 more source

Woman with a Painful Rash

open access: yesClinical Practice and Cases in Emergency Medicine
Case presentation: A 21-year-old woman with a history of eczema presented to the emergency department with a painful rash over the previous three days spreading from her left axilla to her left arm, left chest and left abdominal wall.
Leyan Shalabi, Wesley Eilbert
doaj   +1 more source

Eczema herpeticum in a patient with atopic dermatitis, coxsackie B virus, and staphylococcal infection: A double skin damage

open access: yesIndian Journal of Paediatric Dermatology, 2018
Eczema herpeticum is a rare viral skin scattered infection whose main etiologic agents are HSV1–2 and coxsackievirus, but its association with atopic dermatitis suggests that different factors may play a role in this complex phenotype.
Andrea D Pratico   +3 more
doaj   +1 more source

Proteomic analysis of a filaggrin-deficient skin organoid model shows evidence of increased transcriptional-translational activity, keratinocyte-immune crosstalk and disordered axon guidance [PDF]

open access: yes, 2019
Background: Atopic eczema is an itchy inflammatory disorder characterised by skin barrier dysfunction. Loss-of-function mutations in the gene encoding filaggrin ( FLG) are a major risk factor, but the mechanisms by which filaggrin haploinsufficiency ...
A Fabregat   +69 more
core   +2 more sources

Malignant syphilis in human immunodeficiency virus-infected patients

open access: yesDermatologica Sinica, 2015
Syphilis, the “great imitator” of skin diseases, remains a public health problem worldwide. Coinfection by the human immunodeficiency virus (HIV) and syphilis is common and has important clinical consequences.
Wei-Ting Chang   +2 more
doaj   +1 more source

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 841-855, May 2026.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy